The Latest News Stories
Featured Article
-
PrEP – What have I done to deserve this? (Part 3 of 3)
Guest Marc-André LeBlanc is a negative gay man who is taking an antiretroviral drug, Truvada, as pre exposure prophylaxis (PrEP). In the last of three episodes he recounts what it’s like to be taking the pills daily – and how he feels about that.
Top Stories
-
The first anal condom begins clinical trial in Boston
Insert and play. New fangled condoms in development place the bottom on top. -
Aidsmap.com reports about 10% of gay men taking antiretroviral treatment have low levels of HIV detectable in their semen, according to new research. Whether or not this level of HIV in semen is associated with transmission is unknown. -
Is HIV transmission possible when viral load in the blood is undetectable?
From CATIE, HIV viral load, HIV treatment and sexual HIV transmission -
Gaga inspires a pop culture romp
Bob Leahy reviews “Of A Monstrous Child: A Gaga Musical” playing at Buddies in Bad Times Theatre, Toronto until May 26 -
On the anniversary of my being “sober”
Josh Kruger looks back on the day he decided he was finally done with drinking - and asks why we do it. -
Jack Frost is back from a Califiornia vacation. Here’s his trip report -
Call for action on treatment as prevention
Bob Leahy endorses a call for national action, following a new study that reinforces the effect of antiretroviral treatment on prevention of HIV. -
PrEP – What have I done to deserve this? (Part 3 of 3)
Guest Marc-André LeBlanc is a negative gay man who is taking an antiretroviral drug, Truvada, as pre exposure prophylaxis (PrEP). In the last of three episodes he recounts what it’s like to be taking the pills daily – and how he feels about that. -
Candlelight memorial in British Columbia
Vancouver International AIDS Candlelight Memorial on Sunday May 19, 2013 beginning at 7:30pm in Alexandra Park at the Gazebo/Band Stand. -
HIV testing to become more widespread in Canada?
CATIE summarizes a new PHAC testing guide that includes recommendations to promote routine HIV testing -
Aidsmap.com reports consistent decline in partner numbers in US gay men in last decade, but no change in condom use
Opinion Pieces
-
On the anniversary of my being “sober”
Josh Kruger looks back on the day he decided he was finally done with drinking - and asks why we do it. -
Call for action on treatment as prevention
Bob Leahy endorses a call for national action, following a new study that reinforces the effect of antiretroviral treatment on prevention of HIV. -
PrEP – What have I done to deserve this? (Part 3 of 3)
Guest Marc-André LeBlanc is a negative gay man who is taking an antiretroviral drug, Truvada, as pre exposure prophylaxis (PrEP). In the last of three episodes he recounts what it’s like to be taking the pills daily – and how he feels about that.
Health
-
The first anal condom begins clinical trial in Boston
Insert and play. New fangled condoms in development place the bottom on top. -
Aidsmap.com reports about 10% of gay men taking antiretroviral treatment have low levels of HIV detectable in their semen, according to new research. Whether or not this level of HIV in semen is associated with transmission is unknown.
-
Is HIV transmission possible when viral load in the blood is undetectable?
From CATIE, HIV viral load, HIV treatment and sexual HIV transmission
